NYSE
6 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.2574 per share on April 21, 2025, according to a Form 4 filing.

NYSE
13 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells Shares of Kellanova (K) Under 10b5-1 Plan
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.4121 per share on April 14, 2025, according to a Form 4 filing.

NYSE
20 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.0297 per share on April 7, 2025, according to a Form 4 filing.

NYSE
30 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.4386 per share on March 28, 2025, according to a Form 4 filing.

NYSE
37 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K) Under 10b5-1 Plan
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock at a price of $82.3071 per share on March 21, 2025, according to a Form 4 filing.

NYSE
44 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K) at $82.26
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) common stock at a price of $82.2554 per share on March 14, 2025, reducing its holdings to 47,618,280 shares.

NYSE
46 days, 15 hours ago 
K
Kellanova
8-K: Kellanova Secures Mars Guarantee for Senior Notes Following Merger Consent Solicitations
Kellanova successfully obtains Mars' guarantee for its senior notes through consent solicitations, contingent on the completion of their merger.

NYSE
51 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.5498 per share on March 7, 2025, according to a Form 4 filing.

NYSE
51 days, 15 hours ago 
K
Kellanova
10-K/A: Kellanova Files Amendment to 10-K, Providing Detailed Executive Compensation and Governance Information
Kellanova's amended 10-K filing includes comprehensive details on director and executive compensation, corporate governance practices, and related party transactions for the fiscal year ended December 28, 2024.

NYSE
58 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova common stock at a price of $82.6978 per share on February 28, 2025, according to a Form 4 filing.

NYSE
59 days, 15 hours ago 
K
Kellanova
8-K: Kellanova Announces RSU Grants to Named Executive Officers
Kellanova's Board of Directors approved restricted stock unit (RSU) grants to its named executive officers on February 21, 2025, under the Kellanova 2022 Long-Term Incentive Plan.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Nicolas Amaya Reports Acquisition of Restricted Stock Units
Senior Vice President Nicolas Amaya reports the acquisition of restricted stock units and adjustments to common stock holdings.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Charisse Ford Hughes Reports Acquisition of Restricted Stock Units
Senior Vice President Charisse Ford Hughes reports the acquisition of 9,320 restricted stock units of Kellanova common stock.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Howell Melissa A Reports Acquisition of Restricted Stock Units
Senior Vice President Howell Melissa A reports acquisition of 19,600 restricted stock units in Kellanova.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive David Lawlor Reports Acquisition of Restricted Stock Units
Senior Vice President David Lawlor reports the acquisition of restricted stock units in Kellanova.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kris Bahner Reports Acquisition of Restricted Stock Units
Kris Bahner, SVP-Chief Global Corporate Affairs at Kellanova, reports the acquisition of 8,720 restricted stock units on February 21, 2025.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Shumit Kapoor Reports Acquisition of Restricted Stock Units
Senior Vice President of Kellanova, Shumit Kapoor, reports the acquisition of 18,880 restricted stock units.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Chairman and CEO Steven Cahillane Reports Acquisition of Restricted Stock Units
Steven Cahillane, Chairman and CEO of Kellanova, reports the acquisition of 118,560 restricted stock units.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Acquires Restricted Stock Units
Senior Vice President Victor Marroquin acquired 8,470 restricted stock units of Kellanova common stock on February 21, 2025, which vest on February 21, 2028.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Amit Banati Reports Stock Transactions
Senior Vice President Amit Banati reports acquisition of restricted stock units and disposal of common stock.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Lance Rodrigo Reports Acquisition of Restricted Stock Units
Senior Vice President Lance Rodrigo reports acquisition of Kellanova restricted stock units and updates beneficial ownership.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kurt D Forche Reports Acquisition of Restricted Stock Units
Kurt D Forche, VP-Corporate Controller of Kellanova, reports the acquisition of restricted stock units and updates to beneficial ownership of common stock.

NYSE
61 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Chief Legal Officer Reports Acquisition of Restricted Stock Units
Todd W. Haigh, Chief Legal Officer of Kellanova, reports the acquisition of 17,790 restricted stock units and adjustments to common stock holdings.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Amit Banati Reports Stock Transactions
Senior Vice President Amit Banati reports acquisition and disposal of Kellanova common stock and derivative securities, including transactions related to stock options and restricted stock units.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kris Bahner Reports Stock Transactions
Kris Bahner, SVP-Chief Global Corporate Affairs at Kellanova, reports the acquisition and disposal of common stock and derivative securities.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Executive Nicolas Amaya Reports Stock Transactions
Nicolas Amaya, a Senior Vice President at Kellanova, reported the acquisition and disposal of company stock and derivative securities.

NYSE
62 days, 14 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Victor Marroquin Reports Stock Transactions
Senior Vice President Victor Marroquin reports transactions involving Kellanova stock, including the exercise of stock options and restricted stock units, as well as the disposition of shares to cover tax obligations.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Chief Legal Officer Reports Stock Transactions
Todd W. Haigh, Chief Legal Officer of Kellanova, reports the acquisition and disposal of common stock and derivative securities.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive Lance Rodrigo Reports Stock Transactions
Senior Vice President Lance Rodrigo reports exercising stock options and restricted stock units, and disposing of shares to cover taxes.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive David Lawlor Reports Stock Transactions
David Lawlor, a Senior Vice President at Kellanova, reported the acquisition and disposal of company stock and derivative securities.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Chairman and CEO Steven Cahillane Reports Stock Transactions
Steven Cahillane, Chairman and CEO of Kellanova, reports the vesting and disposal of restricted stock units.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kurt D Forche Reports Stock Transactions
Kellanova's VP-Corporate Controller, Kurt D Forche, reports the disposition of shares to cover tax obligations upon vesting of restricted stock units.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Howell Reports Stock Transactions
Melissa A. Howell, Senior Vice President of Kellanova, reports the acquisition and disposal of company stock and restricted stock units on February 21, 2025.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Charisse Ford Hughes Reports Stock Transactions
Charisse Ford Hughes, a Senior Vice President at Kellanova, reported the acquisition and disposal of company stock and restricted stock units on February 21, 2025.

NYSE
62 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Shumit Kapoor Reports Stock Unit Transaction
Senior Vice President Shumit Kapoor of Kellanova reports the disposition of 26,401 common stock units on February 21, 2025.

NYSE
65 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.5005 per share on February 21, 2025, according to a Form 4 filing.

NYSE
65 days, 15 hours ago 
K
Kellanova
10-K: Kellanova's 2024 10-K Filing: Merger Pending, Snacks Lead Growth Amidst Macroeconomic Headwinds
Kellanova's 2024 results highlight a pending merger with Mars, a focus on snacks-led growth, and navigation of complex macroeconomic conditions following the spin-off of WK Kellogg Co.
Delay expected
 
Worse than expected
 

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Executive Victor Marroquin Reports Stock Transactions
Senior Vice President Victor Marroquin reports the disposition of Kellanova stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Executive Rodrigo Lance Reports Stock Transactions
Senior Vice President Rodrigo Lance reports the vesting and disposal of restricted stock units and shares of Kellanova common stock.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Executive David Lawlor Reports Stock Transactions
David Lawlor, a Senior Vice President at Kellanova, reported the vesting and subsequent disposal of restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Shumit Kapoor Reports Stock Transactions
Senior Vice President of Kellanova, Shumit Kapoor, reports the acquisition and disposal of common stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Executive Charisse Ford Hughes Reports Stock Transactions
Senior Vice President Charisse Ford Hughes of Kellanova reports the acquisition and disposal of common stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Executive Howell Reports Stock Transactions
Senior Vice President Melissa A. Howell of Kellanova reports the vesting and subsequent sale of restricted stock units.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Chief Legal Officer Reports Stock Transactions
Todd W. Haigh, Chief Legal Officer of Kellanova, reports the acquisition and disposal of company stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova VP-Corporate Controller Kurt D Forche Reports Stock Transactions
Kurt D Forche, VP-Corporate Controller of Kellanova, reports the acquisition and disposal of common stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Chairman and CEO Steven Cahillane Reports Stock Transactions
Steven Cahillane, Chairman and CEO of Kellanova, reports the acquisition and disposal of company stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Amit Banati Reports Stock Transactions
Senior Vice President Amit Banati of Kellanova reports the acquisition and disposal of common stock and restricted stock units on February 18, 2025.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova SVP-Chief Global Corp Affairs, Kris Bahner, Reports Stock Transactions
Kris Bahner, SVP-Chief Global Corp Affairs at Kellanova, reports the vesting and subsequent sale of restricted stock units.

NYSE
66 days, 13 hours ago 
K
Kellanova
Form 4: Kellanova Executive Nicolas Amaya Reports Stock Transactions
Senior Vice President Nicolas Amaya reports the acquisition and disposal of Kellanova common stock and restricted stock units on February 18, 2025.

NYSE
72 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.2528 per share on February 14, 2025, according to a Form 4 filing.

NYSE
72 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Director Stephanie Burns Reports Changes in Beneficial Ownership
Director Stephanie Burns reports a transaction involving phantom stock units and indirect ownership of common stock in Kellanova.

NYSE
72 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Director Gund Reports Changes in Beneficial Ownership
Director G. Zachary Gund reports changes in beneficial ownership of Kellanova shares, including acquisitions of phantom stock units and holdings in various trusts and partnerships.

NYSE
76 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $82.2309 per share on February 10, 2025, according to a Form 4 filing.

NYSE
81 days, 0 hours ago 
K
Kellanova
8-K: Kellanova Reports Strong Q4 and Full Year 2024 Results Amidst Pending Mars Acquisition
Kellanova announced strong fourth quarter and full year 2024 results, marked by organic growth and improved profitability, while preparing for its acquisition by Mars, Incorporated.
Better than expected
 

NYSE
89 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $81.9092 per share on January 28, 2025, according to a Form 4 filing.

NYSE
96 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $81.6862 per share on January 21, 2025, according to a Form 4 filing.

NYSE
103 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $81.4214 per share on January 14, 2025.

NYSE
110 days, 13 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova stock at a price of $81.2809 per share on January 7, 2025.

NYSE
118 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.8464 per share on December 30, 2024, according to a Form 4 filing with the SEC.

NYSE
125 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells Shares of Kellanova (K) Under 10b5-1 Plan
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.6424 per share on December 23, 2024, according to a Form 4 filing.

NYSE
132 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $80.6892 per share on December 16, 2024.

NYSE
136 days, 15 hours ago 
K
Kellanova
8-K: Kellanova Secures $750 Million Credit Facility, Replacing Existing Agreement
Kellanova has entered into a new $750 million unsecured 364-Day Credit Agreement, replacing its previous facility and providing funds for general corporate purposes.

NYSE
139 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova stock at a price of $80.6986 per share on December 9, 2024.

NYSE
149 days, 18 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $81.2129 per share on November 29, 2024.

NYSE
157 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $80.9916 per share on November 21, 2024.

NYSE
160 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Executive Kris Bahner Reports Stock Transactions
Kellanova's SVP-Chief Global Corporate Affairs, Kris Bahner, reported the acquisition and disposal of company stock and restricted stock units on November 16, 2024.

NYSE
164 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova Stock
The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $81.0448 per share.

NYSE
164 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Director Stephanie Burns Reports Acquisition of Phantom Stock Units
Director Stephanie Burns of Kellanova reported the acquisition of 162.82 phantom stock units, as well as holding 31,293.436 common shares in trust.

NYSE
164 days, 15 hours ago 
K
Kellanova
Form 4: Kellanova Director G. Zachary Gund Reports Acquisition of Phantom Stock Units
Director G. Zachary Gund reported the acquisition of 325.64 phantom stock units in Kellanova, along with holdings of common stock through various trusts and partnerships.

NYSE
171 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.8862 per share on November 7, 2024, according to a Form 4 filing with the SEC.

NYSE
175 days, 2 hours ago 
K
Kellanova
8-K: Kellanova Shareowners Approve Merger with Acquiror 10VB8, LLC
Kellanova shareholders have approved the merger agreement with Acquiror 10VB8, LLC, paving the way for the company to become a wholly-owned subsidiary.

NYSE
179 days, 0 hours ago 
K
Kellanova
10-Q: Kellanova Reports Q3 2024 Results Amidst Proposed Merger
Kellanova's Q3 2024 results show a slight decrease in net sales but an increase in operating profit, while the company navigates a proposed merger with Mars, Incorporated.
Better than expected
 
Delay expected
 

NYSE
179 days, 1 hours ago 
K
Kellanova
DEFA14A: Kellanova Reports Strong Q3 Results Amidst Pending Acquisition by Mars
Kellanova announced strong third-quarter results, driven by organic growth and improved profitability, while awaiting shareholder approval for its acquisition by Mars, Incorporated.
Better than expected
 

NYSE
179 days, 1 hours ago 
K
Kellanova
8-K: Kellanova Reports Strong Q3 Results Amidst Pending Mars Acquisition
Kellanova announced strong third-quarter results for 2024, marked by double-digit operating profit and earnings per share growth, while a merger with Mars, Incorporated is pending.
Better than expected
 

NYSE
181 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.7609 per share on October 28, 2024, according to a Form 4 filing.

NYSE
188 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.9598 per share on October 21, 2024, according to a Form 4 filing.

NYSE
188 days, 16 hours ago 
K
Kellanova
DEFA14A: Kellanova Addresses Lawsuits and Demand Letters Related to Mars Merger with Supplemental Disclosures
Kellanova is supplementing its definitive proxy statement with additional disclosures to address claims made in lawsuits and demand letters regarding the proposed merger with Mars, Incorporated.

NYSE
188 days, 16 hours ago 
K
Kellanova
8-K: Kellanova Amends Proxy Statement Following Merger Lawsuits and Shareholder Demands
Kellanova has supplemented its definitive proxy statement related to its merger with Acquiror 10VB8, LLC, following lawsuits and demand letters from shareholders alleging misrepresentations and omissions.
Worse than expected
 

NYSE
194 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.6254 per share on October 14, 2024, according to a Form 4 filing.

NYSE
198 days, 16 hours ago 
K
Kellanova
DEFA14A: Kellanova Urges Stockholders to Vote on Proposed Merger
Kellanova is soliciting proxies for a special meeting of stockholders to approve a proposed merger, with voting directions due by October 29, 2024.

NYSE
202 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.5651 per share on October 7, 2024, according to a Form 4 filing with the SEC.

NYSE
205 days, 15 hours ago 
K
Kellanova
DEFA14A: Kellanova Special Meeting Set for November 1, 2024, to Vote on Proposed Merger with Mars
Kellanova has scheduled a special meeting on November 1, 2024, for stockholders to vote on the proposed merger with Mars.

NYSE
209 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.7196 per share on September 30, 2024, according to a Form 4 filing with the SEC.

NYSE
213 days, 16 hours ago 
K
Kellanova
DEFM14A: Kellanova Shareowners to Vote on $83.50 Per Share Merger Agreement with Mars, Incorporated
Kellanova's shareowners are set to vote on a proposed merger agreement with Mars, Incorporated, where each share will be acquired for $83.50 in cash.

NYSE
216 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.6845 per share on September 23, 2024, according to a Form 4 filing with the SEC.

NYSE
223 days, 16 hours ago 
K
Kellanova
DEFA14A: Kellanova CEO Visits Mars, Highlights Synergies Ahead of Proposed Acquisition
Kellanova's CEO, Steve Cahillane, visited Mars' offices to discuss the proposed acquisition and potential synergies between the two companies.

NYSE
223 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.6548 per share on September 16, 2024, according to a Form 4 filing.

NYSE
227 days, 16 hours ago 
K
Kellanova
DEFA14A: Mars to Acquire Kellanova for $35.9 Billion, Uniting Snacking Giants
Mars, Incorporated has agreed to acquire Kellanova for $83.50 per share in cash, a deal valued at $35.9 billion, aiming to create a leading snacking business.

NYSE
230 days, 14 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 114,583 shares of Kellanova (K) at a price of $80.2508 per share on September 9, 2024, according to a Form 4 filing with the SEC.

NYSE
230 days, 16 hours ago 
K
Kellanova
DEFA14A: Mars to Acquire Kellanova's Snacking Business in $33 Billion Deal
Kellanova's snacking business is set to be acquired by Mars, Inc., creating a world-class snacking business with a combined value of approximately $33 billion.

NYSE
242 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $80.6196 per share on August 28, 2024, according to a Form 4 filing.

NYSE
244 days, 15 hours ago 
K
Kellanova
DEFA14A: Mars to Acquire Kellanova in $50 Billion Deal, Shaping the Future of Snacking
Mars, Incorporated will acquire Kellanova in a transaction expected to close in the first half of 2025, aiming to combine complementary strengths in geography and product categories.

NYSE
249 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $80.3226 per share on August 21, 2024, according to a Form 4 filing with the SEC.

NYSE
251 days, 16 hours ago 
K
Kellanova
DEFA14A: Mars to Acquire Kellanova in $35.9 Billion Deal, Shaping the Future of Snacking
Mars, Incorporated has agreed to acquire Kellanova for $83.50 per share in cash, totaling $35.9 billion, aiming to create a global snacking leader.

NYSE
255 days, 15 hours ago 
K
Kellanova
DEFA14A: Kellanova Addresses Facility Concerns Amid Mars Acquisition
Kellanova attempts to reassure stakeholders regarding facility closures and job security following the announcement of its acquisition by Mars, Inc.

NYSE
256 days, 15 hours ago 
K
Kellanova
DEFA14A: Mars, Incorporated to Acquire Kellanova in $35.9 Billion Deal, Shaping the Future of Snacking
Mars, Incorporated and Kellanova have entered into a definitive agreement for Mars to acquire Kellanova for $83.50 per share in an all-cash transaction valued at $35.9 billion, creating a global snacking powerhouse.
Better than expected
 

NYSE
256 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $80.0452 per share on August 14, 2024, according to a Form 4 filing with the SEC.

NYSE
256 days, 16 hours ago 
K
Kellanova
DEFA14A: Kellanova to Merge with Mars, Inc. in Landmark Deal
Kellanova (formerly Kellogg) is set to merge with Mars, Incorporated, pending stockholder and regulatory approvals, becoming a wholly-owned subsidiary of Acquiror 10VB8, LLC.

NYSE
256 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Gund Reports Changes in Beneficial Ownership
Director Zachary Gund reports changes in beneficial ownership of Kellanova shares, including acquisitions of phantom stock units and holdings through various trusts and partnerships.

NYSE
256 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Stephanie Burns Reports Changes in Beneficial Ownership
Director Stephanie Burns reports changes in beneficial ownership of Kellanova shares, including phantom stock units, as of August 14, 2024.

NYSE
257 days, 1 hours ago 
K
Kellanova
DEFA14A: Mars to Acquire Kellanova for $35.9 Billion, Uniting Snacking and Food Giants
Mars, Incorporated will acquire Kellanova in an all-cash transaction valued at $35.9 billion, combining iconic snacking and food brands to create a global leader.
Capital raise
 

NYSE
257 days, 1 hours ago 
K
Kellanova
8-K: Mars to Acquire Kellanova for $35.9 Billion, Uniting Iconic Snacking and Food Brands
Mars, Incorporated has agreed to acquire Kellanova for $83.50 per share in cash, a deal valued at $35.9 billion, including assumed net leverage.
Better than expected
 

NYSE
263 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $74.0084 per share on August 7, 2024, according to a Form 4 filing with the SEC.

NYSE
269 days, 16 hours ago 
K
Kellanova
10-Q: Kellanova Reports Mixed Q2 Results Amidst Restructuring and Currency Headwinds
Kellanova's second-quarter results show a mix of organic sales growth and currency-related challenges, alongside strategic restructuring efforts.
Better than expected
 

NYSE
270 days, 1 hours ago 
K
Kellanova
8-K: Kellanova Exceeds Expectations in Q2, Raises Full-Year Outlook
Kellanova reported strong second-quarter results, driven by organic growth and improved profitability, leading to an increased full-year outlook.
Better than expected
 

NYSE
272 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Kellanova Shares
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $57.2346 per share on July 29, 2024, according to a Form 4 filing.

NYSE
279 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $57.6656 per share on July 22, 2024, according to a Form 4 filing with the SEC.

NYSE
286 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $56.1945 per share on July 15, 2024, according to a Form 4 filing.

NYSE
293 days, 17 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $56.1364 per share on July 8, 2024, according to a Form 4 filing with the SEC.

NYSE
303 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $57.6425 per share on June 28, 2024, according to a Form 4 filing.

NYSE
310 days, 17 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $57.7051 per share on June 21, 2024, according to a Form 4 filing.

NYSE
317 days, 17 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $57.8853 per share on June 14, 2024, according to a Form 4 filing.

NYSE
324 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $59.921 per share on June 7, 2024, according to a Form 4 filing with the SEC.

NYSE
334 days, 17 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $60.1624 per share on May 28, 2024, according to a Form 4 filing with the SEC.

NYSE
338 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Zachary Gund Reports Share Transfers Related to Family Partnerships and Trusts
Director Zachary Gund reports transactions involving Kellanova shares held in family partnerships and trusts, with a pro rata distribution of shares and disclaimers of beneficial ownership except to the extent of his pecuniary interest.

NYSE
341 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $62.0066 per share on May 21, 2024, according to a Form 4 filing with the SEC.

NYSE
346 days, 16 hours ago 
K
Kellanova
8-K: Kellanova Closes $600 Million Senior Notes Offering
Kellanova successfully completed the offering of $300 million in 5.750% Senior Notes due 2054 and 300 million in 3.750% Senior Notes due 2034.
Capital raise
 

NYSE
347 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Stephanie Burns Reports Changes in Beneficial Ownership
Stephanie Burns, a director at Kellanova, reported changes in her beneficial ownership of company stock, including the acquisition of phantom stock units.

NYSE
347 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Gund Reports Changes in Beneficial Ownership
Director Zachary Gund reports changes in beneficial ownership of Kellanova shares, including transactions involving trusts, a limited liability company, and family partnerships.

NYSE
348 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $62.315 per share on May 14, 2024, according to a Form 4 filing with the SEC.

NYSE
353 days, 16 hours ago 
K
Kellanova
8-K: Kellanova Secures $600 Million Through Senior Notes Offering
Kellanova has successfully priced an offering of $600 million in senior notes, split between USD and EUR denominations, to be used for general corporate purposes.
Capital raise
 

NYSE
355 days, 16 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $60.9231 per share on May 7, 2024, according to a Form 4 filing with the SEC.

NYSE
355 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director J Michael Schlotman Acquires Shares
Director J Michael Schlotman acquired 2,915 shares of Kellanova common stock at $60.04 per share on May 6, 2024.

NYSE
355 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Gillum Acquires Shares in Recent Transaction
Director Roderick D. Gillum acquired 2,915 shares of Kellanova common stock at $60.04 per share on May 6, 2024.

NYSE
355 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Erica L. Mann Acquires Shares
Director Erica L. Mann acquired 2,915 shares of Kellanova on May 6, 2024, at a price of $60.04 per share.

NYSE
355 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Donald R. Knauss Acquires Additional Shares
Director Donald R. Knauss reports acquisition of 2,915 Kellanova shares at $60.04 each, increasing his holdings.

NYSE
355 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Carolyn M. Tastad Reports Acquisition of Shares
Director Carolyn M. Tastad reports acquiring 2,915 shares of Kellanova at $60.04 per share on May 6, 2024.

NYSE
355 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Tabron La June Montgomery Acquires Additional Shares
Director Tabron La June Montgomery acquired 2,915 shares of Kellanova common stock at $60.04 per share on May 6, 2024.

NYSE
355 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Gund Reports Acquisition of Common Stock
Director Zachary Gund reports the acquisition of 2,915 shares of Kellanova common stock at $60.04 per share on May 6, 2024, along with holdings in various trusts and partnerships.

NYSE
355 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Carter A. Cast Acquires Shares in Trust
Director Carter A. Cast acquired 2,915 shares of Kellanova common stock at $60.04 per share on May 6, 2024, held indirectly in trust.

NYSE
355 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Mary A. Laschinger Reports Acquisition of Common Stock
Director Mary A. Laschinger reports acquiring 2,915 shares of Kellanova common stock at $60.04 per share on May 6, 2024, increasing her total holdings.

NYSE
355 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Director Stephanie Burns Reports Acquisition of Common Stock
Director Stephanie Burns reported acquiring 2,915 shares of Kellanova common stock at $60.04 per share on May 6, 2024.

NYSE
355 days, 16 hours ago 
K
Kellanova
Form 4: Kellanova Senior Vice President Nicolas Amaya Reports Sale of 9,800 Shares
Nicolas Amaya, a Senior Vice President at Kellanova, reported the sale of 9,800 shares of common stock at an average price of $60.0516 on May 6, 2024.

NYSE
360 days, 16 hours ago 
K
Kellanova
10-Q: Kellanova Reports Mixed Q1 Results Amidst Restructuring and Currency Headwinds
Kellanova's first quarter results show a decrease in reported net sales, but an increase in organic net sales, alongside a rise in operating profit, influenced by restructuring and currency fluctuations.
Better than expected
 

NYSE
361 days, 1 hours ago 
K
Kellanova
8-K: Kellanova Reports Strong Q1 Results, Reaffirms Full-Year Outlook
Kellanova announced strong first-quarter results for 2024, with double-digit operating profit and earnings per share growth, while reaffirming its full-year outlook.
Better than expected
 

NYSE
361 days, 16 hours ago 
K
Kellanova
8-K: Kellanova Amends Charter to Limit Officer Liability, Re-elects Directors at Annual Meeting
Kellanova's shareholders approved an amendment to the company's charter to limit officer liability and re-elected four directors at its annual meeting on April 26, 2024.

NYSE
363 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $58.0028 per share on April 29, 2024, according to a Form 4 filing with the SEC.

NYSE
370 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $57.7556 per share on April 22, 2024, according to a Form 4 filing.

NYSE
377 days, 15 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $55.3477 per share on April 15, 2024, according to a Form 4 filing with the SEC.

NYSE
382 days, 23 hours ago 
K
Kellanova
Form 4: Kellogg W K Foundation Trust Sells 77,800 Shares of Kellanova (K)
The W.K. Kellogg Foundation Trust sold 77,800 shares of Kellanova (K) at a price of $57.4571 per share on April 8, 2024, according to a Form 4 filing with the SEC.

K 
Kellanova 
NYSE

8-K: Kellanova Reports Strong Q1 Results, Reaffirms Full-Year Outlook

Sentiment:
 Quarterly Report
 2 May 2024 8:02 AM

Kellanova announced strong first-quarter results for 2024, with double-digit operating profit and earnings per share growth, while reaffirming its full-year outlook.

Better than expected
  The company's adjusted operating profit and earnings per share growth exceeded expectations, driven by improved profit margins and effective cost management.  The company's free cash flow generation was significantly better than the prior year, indicating improved financial health.  The company's reaffirmation of full-year guidance, despite adverse currency movements, suggests confidence in its underlying performance. 

Summary
  • Kellanova's first-quarter 2024 results showed a 4% decrease in reported net sales year-over-year, primarily due to adverse currency translation and the divestiture of its Russian business.
  • However, organic net sales, which exclude currency and divestiture impacts, increased by 5.4%.
  • Reported operating profit rose by 13.4%, while adjusted operating profit increased by 25.7%, and by 29.6% on a currency-neutral basis.
  • Reported diluted earnings per share increased by 16.4%, and adjusted diluted earnings per share increased by 29.5%, and by 33.3% on a currency-neutral basis.
  • The company reaffirmed its full-year 2024 guidance, projecting organic net sales growth of approximately 3% or better, adjusted operating profit between $1.85 billion and $1.9 billion, and adjusted earnings per share between $3.55 and $3.65.
  • Net cash provided by operating activities was $364 million, a significant increase from $276 million in the prior year, and free cash flow was $209 million, up from $73 million in the prior year.
Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong financial results, particularly in adjusted operating profit and earnings per share, and the reaffirmation of full-year guidance. While there are some challenges noted, the overall tone is optimistic and confident.

Highlights
  • Kellanova's organic net sales grew by 5.4% in the first quarter, despite a 4.3% decrease in reported net sales due to currency and divestiture impacts.
  • The company achieved double-digit growth in both operating profit and earnings per share, with adjusted operating profit increasing by 25.7% and adjusted diluted earnings per share increasing by 29.5%.
  • Currency-neutral adjusted operating profit increased by 29.6%, and currency-neutral adjusted diluted earnings per share increased by 33.3%.
  • Kellanova reaffirmed its full-year 2024 guidance, maintaining its projections for organic net sales growth, adjusted operating profit, and adjusted earnings per share.
  • Free cash flow for the quarter was $209 million, a substantial increase from $73 million in the same period last year.
  • The company's performance was aided by improved gross profit margins, driven by price realization and moderating input-cost inflation.
Positives
  • Organic net sales growth of 5.4% demonstrates underlying strength despite currency headwinds and divestitures.
  • Double-digit growth in operating profit and earnings per share indicates improved profitability.
  • The company's ability to restore profit margins faster than expected is a positive sign.
  • Reaffirmation of full-year guidance provides confidence in the company's future performance.
  • Significant increase in free cash flow suggests improved financial health and flexibility.
  • The company is seeing a moderation of volume declines in developed markets.
Negatives
  • Reported net sales decreased by 4.3% due to adverse currency translation and the divestiture of the Russian business.
  • Europe's reported operating profit decreased by 70% due to network optimization project charges.
  • Latin America's currency-neutral adjusted operating profit decreased by 6%.
  • AMEA's reported net sales decreased by 22% due to adverse foreign currency translation, particularly the Nigerian naira.
  • The company experienced volume pressures across categories due to price elasticities.
Risks
  • Adverse foreign currency translation continues to negatively impact reported results, particularly in AMEA.
  • Industry-wide volume softness and price elasticities are creating challenges.
  • Network optimization projects are incurring up-front charges that are impacting operating profit.
  • The company is facing continued high costs in some regions.
  • There is uncertainty in the full-year financial impact of mark-to-market adjustments and foreign currency translation.
Future Outlook

Kellanova reaffirmed its full-year 2024 guidance, projecting organic net sales growth of approximately 3% or better, adjusted operating profit between $1.85 billion and $1.9 billion, and adjusted earnings per share between $3.55 and $3.65. The company expects free cash flow to be approximately $1.0 billion.

Management Comments
  • Steve Cahillane, Kellanova's Chairman, President and Chief Executive Officer, stated that the company delivered another strong financial performance in the first quarter, marked by improving profit margins.
  • He also noted that there are tangible signs that this year's return to full commercial activity is taking hold in the marketplace and beginning to restore volume and share.
  • Cahillane emphasized that the company's ability to deliver these results amidst challenging macroeconomic and industry conditions is a testament to the more growth-oriented and more profitable portfolio of Kellanova after the spin-off.
Industry Context

Kellanova's results are being achieved amidst challenging macroeconomic and industry conditions, including industry-wide volume softness and currency devaluations in certain emerging markets. The company is managing through these challenges by focusing on price realization, productivity initiatives, and brand investment. The results indicate that the company's strategy post-spin-off is proving effective in a difficult environment.

Comparison to Industry Standards
  • Kellanova's organic net sales growth of 5.4% is a strong result compared to many packaged food companies that are facing volume declines and inflationary pressures.
  • The company's double-digit growth in adjusted operating profit and earnings per share is also notable, as many competitors are struggling to maintain profitability.
  • Companies like Mondelez International and Nestle have also reported facing similar challenges with currency fluctuations and input cost inflation, making Kellanova's performance relatively strong in comparison.
  • The reaffirmation of full-year guidance is a positive signal, as some competitors have been revising their outlooks downwards due to market volatility.
  • The increase in free cash flow is also a positive indicator, as it provides the company with more financial flexibility than some of its peers.
Stakeholder Impact
  • Shareholders will likely view the strong financial results and reaffirmed guidance positively.
  • Employees may be encouraged by the company's performance and future outlook.
  • Customers may benefit from the company's continued investment in innovation and brand development.
  • Suppliers may see the company's financial stability as a positive sign.
  • Creditors may view the company's improved cash flow and profitability favorably.
Next Steps
  • Kellanova will host a conference call on May 2, 2024, to discuss the results and outlook.
  • The company will continue to focus on its commercial plans and initiatives to improve profit margins.
  • The company will continue to monitor and manage the impact of foreign exchange rates and industry-wide volume pressures.
Key Dates
  • May 2, 2024: Date of the press release announcing Q1 2024 financial results and the date of the 8-K filing.
  • March 30, 2024: End date of the first quarter of 2024.
  • April 1, 2023: End date of the first quarter of 2023, used for year-over-year comparisons.
  • August, 2023: Date when the company first provided its 2024 financial guidance.
  • October 2, 2023: Date the company completed the separation transaction.
Keywords
Kellanova, Financial Results, Q1 2024, Organic Growth, Operating Profit, Earnings Per Share, Full-Year Outlook, Snacks, Currency Translation, Divestiture, Free Cash Flow, Profit Margins

K 
Kellanova 
NYSE
Sector: TBD
 
Filings with Classifications
Delay expected
21 February 2025 4:16 PM

Annual Results
  • The exact timing of the completion of the Merger, if at all, cannot be predicted with any certainty.
Worse than expected
21 February 2025 4:16 PM

Annual Results
  • Net sales decreased 2.8% year-over-year, indicating a decline in overall revenue.
Better than expected
6 February 2025 8:02 AM

Earnings Release
  • The company's organic growth exceeded expectations.
  • Profit margins improved faster than anticipated.
  • Earnings per share showed double-digit growth.
Better than expected
31 October 2024 8:10 AM

Quarterly Report
  • The company's operating profit increased by 10% year-over-year, indicating better than expected profitability.
  • Diluted EPS increased by 84% to $1.05, showing better than expected earnings.
  • Currency-neutral adjusted operating profit increased by 19%, demonstrating better than expected underlying performance.
Delay expected
31 October 2024 8:10 AM

Quarterly Report
  • The merger with Mars is expected to close in the first half of 2025, but the exact timing cannot be predicted with certainty, indicating a potential delay.
Better than expected
31 October 2024 8:09 AM

Financial News Release
  • Kellanova's Q3 results exceeded expectations with double-digit operating profit growth and strong earnings per share growth.
  • Organic net sales growth of 6.1% surpassed the company's long-term target range.
Better than expected
31 October 2024 8:08 AM

Quarterly Report
  • The company's organic net sales growth of 6.1% exceeded expectations.
  • The company's double-digit operating profit growth was better than expected.
  • The company's earnings per share growth was better than expected.
Worse than expected
21 October 2024 4:14 PM

Merger Update
  • The document indicates that the company is facing lawsuits and demand letters, which suggests that the initial proxy statement was not well-received by some shareholders.
  • The need for supplemental disclosures implies that the initial disclosures were inadequate or misleading, which is a negative development.
Better than expected
14 August 2024 5:11 PM

Merger Announcement
  • The acquisition price of $83.50 per share represents a significant premium over the recent trading price of Kellanova stock, indicating a better-than-expected outcome for shareholders.
Capital raise
14 August 2024 7:32 AM

Merger Announcement
  • Mars intends to fully finance the acquisition through a combination of cash-on-hand and new debt, for which commitments have been secured.
Better than expected
14 August 2024 7:25 AM

Merger Announcement
  • The acquisition price represents a significant premium over Kellanova's recent trading price, indicating a better than expected outcome for shareholders.
Better than expected
1 August 2024 4:15 PM

Quarterly Report
  • The company's operating profit increased by 18% year-over-year, indicating better than expected profitability.
  • Currency-neutral adjusted operating profit increased by 16%, showing better than expected operational performance.
  • Diluted EPS increased by 17.6% to $1.00, and currency-neutral adjusted diluted EPS increased by 14.4% to $1.03, both better than expected.
Better than expected
1 August 2024 8:03 AM

Quarterly Report
  • Kellanova's results exceeded expectations due to strong organic growth, improved profitability, and increased full-year guidance.
Capital raise
16 May 2024 4:31 PM

Debt Offering Announcement
  • Kellanova raised $300 million through the issuance of 5.750% Senior Notes due 2054.
  • Kellanova also raised 300 million through the issuance of 3.750% Senior Notes due 2034.
Capital raise
9 May 2024 4:59 PM

Debt Offering Announcement
  • Kellanova raised $600 million through the issuance of senior notes.
  • The offering was split between $300 million in USD denominated notes and 300 million in EUR denominated notes.
Better than expected
2 May 2024 4:13 PM

Quarterly Report
  • The company's currency-neutral adjusted operating profit increased by 30%, indicating better than expected operational performance.
  • Currency-neutral adjusted diluted EPS grew by 33%, reflecting better than expected earnings growth.
Better than expected
2 May 2024 8:02 AM

Quarterly Report
  • The company's adjusted operating profit and earnings per share growth exceeded expectations, driven by improved profit margins and effective cost management.
  • The company's free cash flow generation was significantly better than the prior year, indicating improved financial health.
  • The company's reaffirmation of full-year guidance, despite adverse currency movements, suggests confidence in its underlying performance.
Delay expected
20 February 2024 4:20 PM

Annual Results
  • The document mentions that supply pressures are generally decreasing, though weather and geopolitical issues are resulting in other disruptions and logistical delays into 2024.
Better than expected
20 February 2024 4:20 PM

Annual Results
  • The company's organic net sales growth of 8.3% exceeded expectations.
  • The company's operating profit increased by 24.3%, indicating better than expected profitability.
  • The company's currency-neutral adjusted diluted EPS of $3.18 was better than expected.
Better than expected
8 February 2024 8:06 AM

Quarterly Report
  • The company's fourth-quarter results exceeded previous guidance for net sales, operating profit, and earnings per share.

Disclaimer: This summary was generated by artificial intelligence and its accuracy is not guaranteed. The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.